Skip to main content
S&P 5007,743.41+0.51%DOW51,828.62+0.93%NASDAQ27,068.72+0.48%BTC$83,896.00-0.86%ETH$2,687.00-0.12%GOLD$4,320.50+0.52%OIL$92.44-2.29%
Smart Investors Daily
CO

NASDAQ · COCH

Envoy Medical, Inc.

Healthcare · Medical - Devices

$0.72

Down-$0.00 (-0.15%)

Updated Sep 26, 2026, 5:35 AM

SID Score

4.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
17.26M
P/E ratio
-0.75
Dividend yield
0.00%
52-week range
$0.36 – $1.89
Volume
55.05K
Avg. volume
3.01M

Price performance

COCH price history

1M range · 20 trading sessions · Daily adjusted prices

COCH closed at $0.72 after 20 trading sessions, up 3.61% for the selected period.

Last close
$0.72
Period change
+3.61%
Period low
$0.68
Period high
$0.74
Daily close
View OHLC price history
COCH OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 25, 2026$0.6904$0.7284$0.6904$0.71555.05K
Sep 24, 2026$0.7291$0.7385$0.7001$0.716139.56K
Sep 23, 2026$0.7183$0.73$0.715$0.72233.57K
Sep 22, 2026$0.7004$0.7299$0.7004$0.715433.42K
Sep 21, 2026$0.6933$0.725$0.693$0.710581.29K
Sep 18, 2026$0.67$0.7139$0.67$0.713948.51K
Sep 17, 2026$0.7314$0.7314$0.6801$0.6802175.2K
Sep 16, 2026$0.71$0.7261$0.71$0.710174.39K
Sep 15, 2026$0.73$0.76$0.71$0.7136.1K
Sep 14, 2026$0.75$0.753$0.7275$0.730151.99K
Sep 11, 2026$0.692$0.75$0.692$0.7402109.76K
Sep 10, 2026$0.69$0.7199$0.69$0.7117.16K
Sep 9, 2026$0.691$0.71$0.69$0.690337.25K
Sep 8, 2026$0.72$0.7295$0.71$0.711145.93K
Sep 4, 2026$0.71$0.7301$0.7004$0.7128.15K
Sep 3, 2026$0.7199$0.7342$0.6902$0.730184.62K
Sep 2, 2026$0.7272$0.7272$0.682$0.68957.53K
Sep 1, 2026$0.729$0.729$0.7006$0.704426.7K
Aug 31, 2026$0.6926$0.73$0.6926$0.72929.35K
Aug 28, 2026$0.759$0.759$0.6901$0.690149.04K

Latest COCH news

The latest Smart Investors Daily articles mentioning COCH.

Stock researchCompany · Overview

COCH research

Overview

Company profile and research snapshot.

Company profile

Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$6.00
Implied upside
—
Analysts
—
COCH recent ratings
DateFirmRatingTarget
Aug 21, 2026HC Wainwright & Co.Buy—
Jul 27, 2026LUCID CAPITAL MARKETSBuy—
Jul 15, 2026HC Wainwright & Co.Buy—
Mar 31, 2026HC Wainwright & Co.Buy—
May 27, 2025Ascendiant CapitalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 22, 2026

Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio

Canadian and Hong Kong Patents Continue to Strengthen Intellectual Property Protection Across Envoy Medical's Fully Implanted Hearing PlatformWhite Bear Lake, Minnesota--(Newsfile Corp. - September 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the grant of two additional international patents, expanding its global intellectual property portfolio to 97 patents, consisting of

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By